相关实验视频
Updated: Jan 7, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
通过人工智能 (CAD4TB) 和便Xpert MTB/RIF测试改善结核病诊断:来自埃塞俄比亚奥罗米亚的一个前性研究
Giacomo Guido1, Berhanu Gulo2, Sergio Cotugno1
1Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Clinic of Infectious Diseases, University of Bari "Aldo Moro," Bari, Italy.
Open forum infectious diseases
|December 29, 2025
概括
计算机辅助检测软件 (CAD4TB) 和基于便的Xpert MTB/RIF测试改善了埃塞俄比亚家庭接触者的结核病检测. 这种综合方法对于早期发现病例至关重要,特别是在无法产生唾液的儿童和成人中.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 诊断的准确性 诊断的准确性
背景情况:
- 结核病 (TB) 是全球主要的传染性死亡原因,埃塞俄比亚面临着结核病和艾滋病毒/结核病联合感染的高负担.
- 诊断方面的挑战,特别是无法产生的家庭接触者 (HHC),阻碍了早期发现结核病例.
- 计算机辅助检测 (CAD) 软件用于放射和非呼吸道分子分析,如便式Xpert MTB/RIF,提供了有前途的可扩展查策略.
研究的目的:
- 评估CAD4TB软件和基于便的Xpert MTB/RIF测试在埃塞俄比亚家庭接触者中识别结核病的诊断准确性.
- 评估这些工具在高负担,低资源环境中的有效性,特别是对于无法提供唾液样本的个人.
主要方法:
- 在埃塞俄比亚奥罗米亚的圣卢克天主教医院,对478名参与者 (152名结核指数患者,326名HHC) 进行了前性诊断准确性研究.
- 4岁及以上的HHC接受了数字胸部X射线扫描 (有或没有CAD4TB辅助),并为Xpert MTB/RIF测试提供了便和唾液样本.
- CAD4TB和便Xpert的准确性与吐Xpert测试作为参考标准进行了比较.
主要成果:
- CAD4TB表现出强的性能:灵敏度为0.77 (95% CI,0.70-.83) 和特异性为0.93 (95% CI,0.90-.96),在成年人中准确度高于儿童.
- 便和唾液Xpert测试显示高一致性 (科恩的 κ = 0.76),灵敏度为0.77 (95% CI, .70- .84) 和特异性为0.97 (95% CI, .93- .99).
- 这项研究确定了10.6%的HHCs被新诊断为结核病.
结论:
- 联合使用CAD4TB和便Xpert测试显著提高了在高负担,低资源环境中的HHCs中结核病检测率.
- 这种策略对于在不能产生的儿童和成年人以及在放射专业知识有限的地区诊断结核病特别有价值.
- 实施这些先进的诊断工具可以改善早期病例发现,并为结核病控制工作做出贡献.
相关概念视频
Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
Pulmonary Tuberculosis V
520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Serum Laboratory Studies, Stool Test, Breath Test
722
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
722
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III
884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
884

